Recent Headlines
Within Biopharmaceuticals & Biotherapeutics

MoBiTec GmbH, Germany, is Offering Nuclear Receptor Fusion Proteins That Are of Importance to the Pharmaceutical Industry for FRET Interaction Studies

MoBiTec GmbH, Germany, supplier of research tools, introduces a collection of Nuclear Receptor-Ligand Binding Domain fusion proteins, carrying a GST tag, capable to bind a Europium-anti-GST antibody. With this the influence of fluorophore-labeled peptides on the ligand binding characteristics can be studied. E.g. the addition of a particular peptide might prevent the receptor from binding a ligand, thereby eliminating a response of a cell to a given stimulus. - August 17, 2011 - MoBiTec GmbH

Mouse Monoclonal DUX4 Antibody Announced by Novus Biologicals

DUX4 is a transcriptional activator of PITX1, whose expression is epigenetically suppressed in differentiated tissues. DUX4 defects are suspected to cause facioscapulohumeral dystrophy (FSHD), a degenerative skeletal muscle disease and one of the most common muscular dystrophies. In FSHD... - August 17, 2011 - Novus Biologicals

AnaSpec Offers Monoclonal Antibody, Anti-5-Methylcytidine

AnaSpec, EGT Group is pleased to offer Eurogentec’s popular monoclonal antibody, anti-5-methylcytidine (Clone 33D3) for use in epigenetics research. Purified from ascites, this IgG1 / λ isotype antibody is supplied as a 1 mg/ml solution (in PBS) and is available in three sizes (0.1 mg,... - August 14, 2011 - AnaSpec, EGT Group

AnaSpec Highlights Calcein AM with High Purity Grades

AnaSpec is pleased to provide Calcein AM at two purity grades, >90% or >95%, as determined by HPLC. AnaSpec also offers the SensoLyte® Calcein Cell Viability Assay Kit - a rapid and sensitive assay to detect viable cells. This kit provides ample reagents (dye and assay buffer) for 1000... - August 14, 2011 - AnaSpec, EGT Group

Mitegen Announces Distribution of AP Innovation's Quick Puck Loader

Innovative Tool increases speed and reduces errors during puck loading - August 03, 2011 - MiTeGen, LLC

Mouse Monoclonal ABCG8 Antibody Announced by Novus Biologicals

Novus Biologicals announced today a new mouse monoclonal ABCG8 antibody. ABCG8 is an ATP binding cassette family member which acts to exclude non-cholesterol sterol entry to the intestine, to promote excretion of cholesterol and sterols into bile, and to facilitate transport of sterols back into... - August 03, 2011 - Novus Biologicals

Novus Biologicals Announces VMAT2 Antibody Made Using SDIX Genomic Antibodies™

Novus Biologicals announced today a new VMAT2 antibody (NBP1-69750) for use in neurotransmission research. This VMAT2 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). VMAT2 is a multipass membrane protein responsible for vesicular transport of neurotransmitters by pumping... - August 01, 2011 - Novus Biologicals

Tracking Environmental Monitoring Trends Crucial to Regulatory Compliance, OsoBio Expert Says

A microbiology laboratory manager at OSO BioPharmaceuticals Manufacturing, LLC, has authored a chapter on environmental monitoring trends for an industry reference manual. Kim Van Antwerpen wrote a chapter for “Environmental Monitoring: A Comprehensive Handbook (vol. 5)” edited by... - July 30, 2011 - OSO BioPharmaceuticals Manufacturing, LLC

Raybiotech Launches Risk-Free Trial Program for ELISA Kits

RayBiotech, Inc., has just launched a Risk-Free Trial on its ELISA kits, stipulating that if a researcher is unsatisfied with the performance of any RayBio® ELISA, EIA, or phosphorylation ELISA, they can receive a full product refund or credit. - July 22, 2011 - RayBiotech, Inc

Valencia Practice Adpots New and Discreet STARR Weight-Loss Treatment

Town Center Surgery’s Dr. Monali Misra praises privacy and comfort of new procedure, no visible scars. - July 21, 2011 - TransEnterix

AnaSpec Releases Anti-LL-37

AnaSpec is pleased to announce the release of a new anti-LL-37. Rabbit Anti-human Cathelicidin LL-37 polyclonal antibody was raised against a synthetic peptide from a sequence found within 134-170 amino acid residues (LL-37) of the LL-37 precursor human cationic antimicrobial protein, hCAP-18... - July 17, 2011 - AnaSpec, EGT Group

AnaSpec Expands SensoLyte® MMP Assay Kits Collection

Since its introduction, AnaSpec, EGT Group’s product line of SensoLyte® 520 MMP Assay Kits has become the new standard in MMP assay sensitivity. These fluorescence resonance energy transfer (FRET)-based assay kits utilizing the 5-FAM/QXL™ 520 are some of the most sensitive and... - July 17, 2011 - AnaSpec, EGT Group

AnaSpec Specializes in Custom Peptide Synthesis

Since 1993, AnaSpec has assisted scientists in the design and synthesis of >50,000 peptides. As a result, AnaSpec's combined knowledge and expertise provide premium solutions to its customers. AnaSpec routinely completes difficult peptide synthesis such as synthesis of long peptides... - July 15, 2011 - AnaSpec, EGT Group

2nd International Conference on Tocotrienols and Chronic Diseases at Wynn Resort, Las Vegas, July 2011

Latest research studies, technical application as well as market potential of palm tocotrienol complex will be shared in this conference. - July 08, 2011 - Carotech Inc.

New Virus Modification Approach to Creating Vaccines for Insect-Borne Diseases

A technology breakthrough that could have a major impact in the development of vaccines to preventive insect-borne diseases has been published in the June edition of Virology Journal, - July 07, 2011 - Arbovax Inc

Novus Biologicals Announces Opening of Canadian Office

Novus Biologicals, an international supplier of antibodies and antibody-related products to bioscience researchers, is proud to announce the opening of their second international office in Oakville, Ontario, Canada. Novus' other offices include Novus Europe, which services Europe from Cambridge,... - June 30, 2011 - Novus Biologicals

Mitegen Awarded $250K NIH STTR Phase II Grant

Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, has been awarded a phase II STTR (small business technology transfer program) award from the NIH (National Institute of Health) for the development of improved crystallization plates. - June 27, 2011 - MiTeGen, LLC

OSO BioPharmaceuticals Receives DEA Approval to Handle Controlled Substances

OSO BioPharmaceuticals Manufacturing, LLC, has been granted research and analytical licenses by the U.S. Drug Enforcement Administration (DEA) to handle Schedule II through V controlled substances. - June 24, 2011 - OSO BioPharmaceuticals Manufacturing, LLC

AnaSpec Offers Custom Assay Development Service

AnaSpec, EGT Group, provider of the long wavelength, ultra-sensitive SensoLyte® assay kits, is pleased to offer custom service for the development of assays. The long wavelength of SensoLyte® protease assays, many of which utilize the 5-FAM/QXL™ 520 and HiLyte Fluor™... - June 23, 2011 - AnaSpec, EGT Group

AnaSpec Highlights Anb-Wang Resin

Colorimetric based Peptide-p-Nitroanilide conjugates (peptide-pNAs), with absorbance at approximately 408 nm, have historically been and are still widely used substrates for the study of protease activity. However, the preparation of peptide-pNA presents technical challenges. The amino group of pNA... - June 23, 2011 - AnaSpec, EGT Group

One-Shot Dengue Fever Vaccine Moves Closer to Reality

Arbovax, Inc. is an early stage biotechnology company based in Raleigh NC, developing a novel and innovative technology to facilitate the development of vaccines against insect-borne viruses. Their initial focus, Dengue Fever, is ranked second only to Malaria by the World Health Organization for its devastating global impact. - June 21, 2011 - Arbovax Inc

MoBiTec Expands Its Selection of High Quality Gene Expression Systems for Bacillus megaterium

Based on its already successful protein expression systems for Bacillus megaterium, MoBiTec GmbH introduces a new family of protein expression vectors, the hp-Expression Systems, for high yield expression in the well-established organism Bacillus megaterium. This new system complements the existing non-E. coli expression systems for B. megaterium, Bacillus subtilis, Lactococcus lactis and yeast. Further non-E. coli expression systems are in preparation. - June 09, 2011 - MoBiTec GmbH

Aciont® to Present at the 13th Annual NIH SBIR/STTR Conference

Dr. Kongnara Papangkorn’s presentation is entitled, “Safety Aspects and Drug Delivery Performance of Visulex® Passive Delivery System” - June 09, 2011 - Aciont Inc.

Carotech to Showcase GRAS-Approved Tocomin Palm Tocotrienol Complex at IFT 2011, New Orleans, Louisiana, USA

Carotech will share applications and benefits of TocoBev tocotrienol beverage powder at IFT. - June 09, 2011 - Carotech Inc.

AnaSpec Introduces DPPIV Assay Kit

AnaSpec, EGT Group is pleased to introduce a new long wavelength fluorimetric assay kit for determining Dipeptidyl Peptidase IV (DPPIV) activity, the SensoLyte® Rh110 DPPIV Assay Kit. This kit contains a substrate that emits in the green range of 520 nm when cleaved by DPPIV. The kit provides a... - May 27, 2011 - AnaSpec, EGT Group

AnaSpec Offers High-Throughput Dispensing Service

AnaSpec, EGT Group is pleased to offer high-throughput dispensing service. Their commitment to supply the life science community with simple, affordable and innovative solutions has resulted in this service: bringing the advantages of automation within everyone’s reach. The fully equipped... - May 27, 2011 - AnaSpec, EGT Group

AnaSpec Introduces Anti- β-Amyloid

AnaSpec, Eurogentec Group is pleased to announce the release of two new mouse monoclonal antibodies specific for β-Amyloid (1-40) & (1-42). These two antibodies are of the IgG1 subtype and do not cross-react with each other at concentrations up to 50 ng/ml when tested in sandwich ELISA. - May 27, 2011 - AnaSpec, EGT Group

AnaSpec Introduces Speedy 28-Day Custom Polyclonal Antibody Service

When traditional protocols can take almost 90 days, the wait for high-quality custom polyclonal antibodies can be excruciating. AnaSpec is pleased to introduce the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol... - May 27, 2011 - AnaSpec, EGT Group

Mitegen Announces Mutual Distribution Agreements with Omscientia

Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed mutual non-exclusive distribution agreements with Omscientia, a... - May 26, 2011 - MiTeGen, LLC

AnaSpec Highlights MMP Inhibitors

AnaSpec, Eurogentec Group, is pleased to release 11 MMP inhibitors to complement their wide offering of MMP SensoLyte® 520 and 490 fluorimetric kits, colorimetric kits, recombinant proteins, and Z-Fish™ antibodies (antibodies specific for zebrafish). These MMP inhibitors are small... - May 25, 2011 - AnaSpec, EGT Group

TransEnterix Receives Global Entrepreneurial TiE50 Award

For demonstrating ingenuity and innovation as a life-science startup company, TransEnterix has received the prestigious TiE50 Award for 2011. The TiE50 Awards are given each year by TiE, the organizer of TiEcon, the world’s largest annual conference for entrepreneurs. One of 10 winners in... - May 14, 2011 - TransEnterix

OSO BioPharmaceuticals Manufacturing LLC Honored for Corporate Efforts to Protect Integrity of Rio Grande

OSO BioPharmaceuticals Manufacturing, LLC, has received the Pollution Prevention Award for its efforts to protect water quality in the Rio Grande River. The honor was awarded by the Albuquerque Bernalillo County Water Utility as part of its Pollution Prevention Program (P2 Program). The P2... - May 13, 2011 - OSO BioPharmaceuticals Manufacturing, LLC

Mitegen Announces Mutual Distribution Agreements with NatX-ray

Improving customer access to industry leading products from both companies. - April 30, 2011 - MiTeGen, LLC

Pacific Biomarkers Inc. Awarded Nine Contracts in Early 2011 for Studies in Immunogenicity, Diabetes and Other Areas

Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, has been awarded by one sponsor, nine contracts in early 2011 with a total value of approximately $920,000. The nine contracts are in the areas... - April 29, 2011 - Pacific Biomarkers Inc

Novus Biologicals Announces New USP22 Antibody Made Using SDIX's Genomic Antibody Technology™

Novus Biologicals announced today a new USP22 antibody (catalog number NBP1-49644) for the study of ubiquitin-dependent metabolic pathways. This USP 22 antibody was made using SDIX's Genomic Antibody TechnologyTM (GATTM). Deubiquitinating enzymes (DUBs) comprise a large group of proteases that... - April 28, 2011 - Novus Biologicals

Novus Biologicals Announces New Nkx6.1 Antibody Made Using SDIX's Genomic Antibody Technology™

Novus Biologicals announced today a new Nkx6.1 antibody (catalog number NBP1-49672) for the study of Pancreatic Stem Cell Markers or Signal Transduction. This Nkx6.1 antibody was made using SDIX's Genomic Antibody TechnologyTM (GATTM). Homeobox protein Nkx-6.1 is a bifunctional transcription... - April 28, 2011 - Novus Biologicals

Novus Biologicals Announces New PINK1 Antibody Made Using SDIX Genomic Antibodies™

Novus Biologicals is excited to announce a new PINK1 antibody (catalog number NBP1-49678) for the study of mitochondrial markers and neurodegeneration. This PINK 1 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). PTEN-induced putative kinase 1 (PINK1) is a mitochondrial... - April 23, 2011 - Novus Biologicals

Carotech to Share Emerging Science Supporting Tocomin®SupraBio™ in Addressing Wellness During SupplySide East Expo, May 3 – 5, 2011

Meet them at Supplyside East (Booth 1710) to learn about the latest science of Tocomin®SupraBio™ - April 20, 2011 - Carotech Inc.

AnaSpec Introduces Industry’s First Zebrafish Specific Antibodies - Z-FishTM Anti-Lysozyme

AnaSpec, Eurogentec Group is pleased to be the first in the industry to establish a new product line of zebrafish specific (Z-Fish™) antibodies to support the increasing needs of researchers. In collaboration with the University of Utah, Salt Lake City, Utah, AnaSpec's Z-Fish™... - April 13, 2011 - AnaSpec, EGT Group

New APE1 Redox Inhibitor Molecule (E3330)

AP Endonuclease 1 (APE1), also known as REF-1, is an enzyme primarily responsible for DNA base excision repair. In addition to a DNA repair domain, APE-1 also contains a redox regulation domain to help activate other enzymes involved in the DNA repair pathway. APE 1 is found overexpressed in many... - April 07, 2011 - Novus Biologicals

TransEnterix Introduces New SPIDER Surgical System

Enhanced design delivers added strength, precision and ergonomics — through tiny incision the size of a dime. - April 01, 2011 - TransEnterix

TransEnterix Continues to Advance Laparoscopic Surgery Through Innovation

New line of 3mm SPIDER MicroLap™ surgical instruments paves way for "freckle" surgery. - March 25, 2011 - TransEnterix

VIRUN Patent Granted Mucosal Adhesive Penetrating Technology Delivering Naive Compounds and Peptides Orally

VIRUN, Inc., a biotechnology research and manufacturer of novel encapsulation and delivery technologies has been granted patent number 7,906,140 titled Compositions for Mucosal Delivery of Agents. The patent was issued following the prosecution and due diligence performed by VIRUN and its team of scientists. - March 23, 2011 - VIRUN

Mitegen Announces Release of Dual Thickness MicroMounts™

Improved crystal mount for X-ray diffraction offers highest rigidity and lowest background scatter - March 22, 2011 - MiTeGen, LLC

Three New Histone Demethylase Antibodies Announced by Novus Biologicals

Novus Biologicals announced today the release of three new rabbit polyclonal antibodies to important histone demethylase proteins: JMJD2C (Catalog# NBP1-49600), JMJD1A (Catalog# NBP1-49601), and JMJD2A (Catalog# NBP1-49602). All three of these new antibodies cross-react with human and mouse... - March 20, 2011 - Novus Biologicals

C. elegans Antibodies from the modENCODE Project Now Available Through Novus Biologicals

Antibodies against 69 C. elegans chromosomal proteins generated by the modENCODE project are now commercially available through Novus Biologicals, SDIX’s pre-made antibody distributor. The modENCODE project (model organism ENCyclopedia Of DNA Elements) is funded by the NIH to identify all of... - March 20, 2011 - Novus Biologicals

Recent Headlines Within Biopharmaceuticals & Biotherapeutics

Recent Headlines
Within Biopharmaceuticals & Biotherapeutics